Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Heron raises $150M in follow-on

    Heron Therapeutics Inc. (NASDAQ:HRTX) raised $150 million through the sale of 12.3 million shares at $12.20 in a follow-on underwritten by BofA Merrill Lynch, Cowen, Leerink, Cantor Fitzgerald, JMP Securities, Noble …

    Published on 1/19/2017
  • FINANCIAL NEWS: Octimet raises EUR 11.3M in series A

    Cancer play Octimet Oncology N.V. (Beerse, Belgium) raised EUR 11.3 million ($12 million) in a series A financing led by V-Bio Ventures and Fund+. DROIA Oncology Ventures and OMNES Capital also participated. Octimet has…

    Published on 1/19/2017
  • FINANCIAL NEWS: Zynerba raises $50.4M in follow-on

    Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) raised $50.4 million through the sale of 2.8 million shares at $18 in a follow-on underwritten by Jefferies, Piper Jaffray, Cantor Fitzgerald, Oppenheimer and Roth Capital …

    Published on 1/19/2017
  • FINANCIAL NEWS: Financial tracks

    H.C. Wainwright hired John Chambers as president and head of investment banking. He was vice chairman and head of healthcare investment banking at Roth Capital Partners. Lilly Asia Ventures named Darren Ji venture …

    Published on 1/18/2017
  • FINANCIAL NEWS: NEA sets $3B target for 16th fund

    New Enterprise Associates has set a $3 billion target for its New Enterprise Associates 16 fund, according to an SEC filing. The firm, which invests in both technology and healthcare, did not respond to inquiries.NEA …

    Published on 1/18/2017
  • FINANCIAL NEWS: Biotechs pull up from Trump dive

    Biotech stocks made a partial recovery late in the week from losses incurred after President-elect Donald Trump blasted the biopharma industry during a press conference Wednesday. Trump said pharma companies are "…

    Published on 1/13/2017
  • FINANCIAL NEWS: Qiming raising $125M fund

    Qiming Venture Partners has set a $125 million target for its planned Qiming U.S. Healthcare Fund L.P., according to an SEC filing. The firm closed its fourth renminbi fund at RMB1.5 billion ($221.4 million) in November…

    Published on 1/13/2017
  • FINANCIAL NEWS: OncoImmune raises $15M in series A

    OncoImmune Inc. (Rockville, Md.) said it raised $15 million in a series A round led by 3E Bioventures Capital. The company's lead candidate, CD24Fc, is in a Phase II study to prevent graft versus host disease (GvHD). …

    Published on 1/12/2017
  • FINANCIAL NEWS: Signet closes $137.2M fourth fund

    Signet Healthcare Partners (New York, N.Y.) closed its fourth fund at $137.2 million. The firm plans to invest the fund in 10-12 commercial stage companies, primarily in the pharmaceutical and medtech sectors.The firm …

    Published on 1/12/2017
  • FINANCIAL NEWS: UCSF receives $500 million donation

    The Helen Diller Foundation donated $500 million to the University of California San Francisco. The gift is the largest ever granted to the university.The donation includes $100 million to retain existing professors and…

    Published on 1/12/2017
  • FINANCIAL NEWS: Takeda invests in cancer play Maverick, with option to buy

    Immuno-oncology company Maverick Therapeutics Inc. (Brisbane, Calif.) raised $23 million in a series B financing from founding investor MPM Capital and Takeda Pharmaceutical Co. Ltd. (Tokyo:4502). In a new partnership, …

    Published on 1/11/2017
  • FINANCIAL NEWS: Adynxx raises $16M in series B

    Pain company Adynxx Inc. (San Francisco, Calif.) raised $16 million in a series B round led by new investor TPG Biotech. Existing investor Domain Associates also participated.Adynxx said it plans to start a Phase II …

    Published on 1/10/2017
  • FINANCIAL NEWS: Labcorp buys into Sera, to distribute preterm birth test

    Sera Prognostics Inc. (Salt Lake City, Utah) raised $40 million in a series C round led by Laboratory Corp. of America Holdings (NYSE:LH). Also participating were existing investors Domain Associates, InterWest Partners…

    Published on 1/10/2017
  • FINANCIAL NEWS: Cavion raises $26.1M series A

    Cavion Inc. (Charlottesville, Va.) raised $26.1 million in a series A round co-led by Lilly Ventures and Novartis Venture Fund. Enso Ventures also participated, as did undisclosed existing investors. The company is …

    Published on 1/6/2017
  • FINANCIAL NEWS: Financial tracks

    Versant Ventures named Clare Ozawa managing director and named Alex Mayweg and Mary Haak-Frendscho venture partners. Ozawa was COO at the firm's Inception Sciences Inc. (San Diego, Calif.) company creation operation, …

    Published on 1/6/2017
  • FINANCIAL NEWS: Frontier raises RMB300M in series C

    Frontier Biotechnologies Co. Ltd. (Nanjing, China) said it raised RMB300 million ($43.2 million) in a series C round led by Huaxin Century. Shenzhen Capital, Efung Capital and undisclosed other investors also …

    Published on 1/6/2017
  • FINANCIAL NEWS: Scangos to lead anti-infectives newco Vir

    Anti-infectives company Vir Biotechnology Inc. (San Francisco, Calif.) launched with an investment round of undisclosed size. Former Biogen Inc. (NASDAQ:BIIB) CEO George Scangos will be the newco's CEO.Vir said Arch …

    Published on 1/6/2017
  • FINANCIAL NEWS: Grail seeking $1B series B round

    Cancer diagnostic company Grail Inc. (Redwood City, Calif.) said undisclosed private and strategic investors have shown interest in participating in its planned $1 billion series B round. Grail hired Goldman Sachs as a …

    Published on 1/5/2017
  • FINANCIAL NEWS: Hatteras closes fifth fund

    Hatteras Venture Partners said it closed Hatteras Venture Partners V with more than $150 million. It plans to invest in therapeutics, devices, diagnostics and healthcare IT companies, with a portion allocated to its …

    Published on 1/5/2017
  • FINANCIAL NEWS: Loxo raises $120M in follow-on

    Loxo Oncology Inc. (NASDAQ:LOXO) raised $120 million through the sale of 3.9 million shares at $31 in a follow-on underwritten by Morgan Stanley, Citigroup, Cowen and Stifel. The price is a 5% discount to Loxo's closing…

    Published on 1/5/2017
  • FINANCIAL NEWS: Neon raises $70M in series B

    Neoantigen vaccine play Neon Therapeutics Inc. (Cambridge, Mass.) raised $70 million in a series B round led by new investor Partner Fund Management. New investors Fidelity, Wellington Management, Inbio Ventures and …

    Published on 1/5/2017
  • FINANCIAL NEWS: NeRRe raises L23M in series B

    NeRRe Therapeutics Ltd. (Stevenage, U.K.) raised L23 million ($28.4 million) in an oversubscribed series B co-led by new investors Fountain Healthcare Partners, Forbion Capital Partners and OrbiMed. Also participating …

    Published on 1/5/2017
  • FINANCIAL NEWS: Shin Nippon spins out Satsuma with $12M series A

    Shin Nippon Biomedical Laboratories Ltd. (Tokyo:2395) spun out migraine company Satsuma Pharmaceuticals Inc. (San Francisco, Calif.) with a $12 million series A round co-led by RA Capital Management and TPG Biotech.…

    Published on 1/5/2017
  • FINANCIAL NEWS: CRISPR tools play Synthego raises $41M in series B

    Synthetic RNA company Synthego Corp. (Redwood City, Calif.) raised $41 million in a series B round led by 8VC. New investors AME Cloud Ventures, Elements Capital, OS Fund, Alexandria Real Estate Equities, ZhenFund, and …

    Published on 1/4/2017
  • FINANCIAL NEWS: Financial tracks

    Novo Ventures promoted Nilesh Kumar to partner from senior principal. Kumar, who is based in the firm's Boston office, was a senior director at Merck Serono Ventures prior to joining Novo Ventures in 2015.Rodman & …

    Published on 1/4/2017

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993